Jim Simons’s RenovoRx RNXT Stock Holding History

Jim Simons’s Portfolio RNXT Stock Details RNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.1K	Sell	13,000 -104,457	-89%	-$101K	﹤0.01%	3191
2025 Q4	$98.7K	Sell	117,457 -196,093	-63%	-$196K	﹤0.01%	3016
2025 Q3	$398K	Buy	313,550 +61,750	+25%	+$73.4K	﹤0.01%	2881
2025 Q2	$331K	Buy	251,800 +224,144	+810%	+$255K	﹤0.01%	3009
2025 Q1	$27.4K	Sell	27,656 -37,244	-57%	-$43.3K	﹤0.01%	3341
2024 Q4	$83.7K	Buy	+64,900	New	+$73.9K	﹤0.01%	3313
2024 Q3	–	Sell	-10,000	Closed	-$11.3K	–	3825
2024 Q2	$11.3K	Buy	+10,000	New	+$12.3K	﹤0.01%	3415

Other funds holding RNXT

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

NPT

Nixon Peabody Trust Boston, Massachusetts $1.41B AUM 27.78% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

Jim Simons's RNXT Position: Q1 2026 in Review

Jim Simons reduced its RenovoRx (RNXT) stake by 89% in Q1 2026, selling an estimated $101K and leaving 13,000 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3191.

Jim Simons first reported a position in RNXT in Q2 2024 and has held it in 7 quarters since. The position peaked at $398K in Q3 2025. 31 funds tracked by Wall St. Rank hold RNXT as of Q1 2026.

Jim Simons held 13,000 shares of RenovoRx worth $13.1K as of Q1 2026.
Jim Simons sold 104,457 RenovoRx shares in Q1 2026, an estimated $101K.
RenovoRx made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3191 holding.
Jim Simons first reported a position in RenovoRx in Q2 2024 and has held it in 7 quarters since.
Jim Simons's RenovoRx position peaked at $398K in Q3 2025.
31 funds tracked by Wall St. Rank held RenovoRx as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.